Abstract
The The understanding of early changes leading to breast cancer is vital for therapeutic strategies. These genetic changes leading to breast cancer can include the loss of nucleotide excision repair mechanism.
2-Breast Cancer Stages:
Breast cancer is classified in different stages based on the size and location of the tumor. Stage 0 is cancer that has not spread beyond the breast ductal system. Two types of stage 0 are often diagnosed: ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) based on which part of the milk duct is affected. However, both seem to arise from earlier non-malignant lesions called terminal ductal lobular units (TDLU). DCIS is also classified into high (comedo), intermediate, and low (non-comedo) based on the nuclear diameter, chromatin integrity and nuclear necrosis (Harris et al., 2000) . All in all, the 5-year relative survival rate for stage 0 is 100%. However, stage 0, especially DCIS, is a marker for higher cancer risk anywhere in the breast. 
3-Familial and Sporadic Breast Cancer:
Generally, solid tumors differ from leukemias. The latter requires one major genetic event for neoplastic transformation, while the former involves multiple genes with complex interactions among normal and mutant genes that allow the cells to escape cell cycle regulations, apoptosis and dependence on growth signals, resulting in limitless cell proliferation, creation of new blood vessels and the ability to metastasize (Hemminki et al., 2001 ). Breast cancer is not an exception from these limitations. A loss in at least one of the DNA repair mechanisms might be a vital step for the purpose of acquiring all these prerequisites. In inherited breast cancer, the first mutation is inherited. The second mutation is acquired through loss of heterozygosity, epigenetic changes or gene mutation. BRCA1 was mapped to 17q21 by Hall and colleagues in 1990 (Hall et al., 1990 However, under excessive DNA damage, BRCA1 might activate apoptosis independent of p53. This is achieved through the induction of Fas-dependent pathway which ends in the activation of procaspase-8 (Bernstein et al. 2002) . All in all, BRCA1 is essential for genomic stability and mutations in both alleles allow the cell to rapidly acquire new mutations (Moynahan, 2002) . Recently, there is evidence that BRCA1 is down regulated or even repressed in the majority of high grade sporadic ductal carcinomas (Shen et al., 2000) . However, most sporadic breast cancers seem to have normal expression for BRCA1.
4-Nucleotide Excision Repair (NER):
DNA damage could occur as a result of a variety of exogenous and endogenous factors, such as UV radiations, free radicals, etc. Such damage could block DNA replication, transcription or could result in mutation, if not repaired. However, both eukaryotic and prokaryotic organisms have developed mechanisms to repair DNA damage. One of these mechanisms is NER. NER functions in repairing damage caused by UV light in the form of bulky adducts, such as; cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidone photoproducts. These lesions are not only chemically different; they also induce a bend in the DNA molecule (Ura et al., 2002) . Consequently, a deficit in NER has broad impact on genomic stability especially after UV exposure.
Classical examples of inherited NER deficiencies are xeroderma pigmentosum (XP), cockayne syndrome (CS) and trichothiodystrophy (TTD-A). These individuals are highly sensitive to UV light and individuals with XP are predisposed to skin cancer.
Interestingly, NER capability seems to be lost in breast tumors and in adjacent non tumor tissue (Latimer et al., 2002) . In eukaryotes, NER consists of four steps. It involves recognition, excision by excinuclease, followed by DNA repair synthesis and ligation of the new DNA strand.
NER functions in two subpathways, global genomic repair (GGR) and transcription coupled repair (TCR). They differ mainly in the initiation step because RNA polymerase (Pol II) in TCR helps recruit the recognition complex to the damage site. The first step is the rate limiting step and it involves the binding of XPA-RPA (Replication Protein A) to the damaged DNA (Sancar, 1996) . Recent reports indicate that this recognition step could also be carried out by other complexes, namely XPC-hHR23B or XPE-XPC (Bernstein et al., 2002) . The complex recruits TFIIH to the lesion which in turn unwinds the double strands of DNA. Both XPA and TFIIH help recruit XPC-hHR23 to the lesion. In addition, both TFIIH and RPA recruit XPG to the damage site. XPG makes a 3 / incision 3-5 bases 3 / to the lesion. Simultaneously, XPA, XPF and TFIIH recruit XPF-ERCC1.
The latter complex makes a 5 / incision 20-24 nucleotides 5 / to the lesion. The postincision complex is dissociated by RFC which also brings DNA synthesis machinery including PCNA in association with Polymerase ε or δ. The gap is filled and DNA ligase I makes two phosphodiester bonds linking the repair fragment (27-29 nt) to the backbone of the DNA molecule (Sancar, 1996) . Table I 
5-Cytogenetics and Molecular Genetics of Breast Cancer:
Cancer is a multistep genetic disease, which shows a very complex pattern of genetic mutations such as chromosomal aberrations. In the case of invasive breast cancers (IBC), there is compelling evidence that they diverged from premalignant stages. For instance, up to 80% of DCIS and LCIS share at least one to several LOHs with synchronous IBC which indicates that they are genetically related (Harris et al., 2000) .
Consequently 
6-SKY:
Since its development by Schrock et al. in 1996, spectral This study is interested in early events in carcinogenesis of breast cancer with a special focus at loss of NER and genetic instability. Several early stage cancer and normal tissue cultures derived from breast cancer patients were karyotyped. In addition, MCF10A cells were cytogenetically studied as a model for early steps in carcinogenesis.
To further elucidate the chromosomal abnormalities present, SKY analysis and multi probe FISH for breast cancer aneusomy were performed on a DCIS case and MCF10A cells.
II. Materials & Methods

1-Regular Karyotype:
Established cell cultures were fed every other day with 5 ml of Alpha MWRI media The cells were incubated in a water bath for 10 min at 37 0 C. The tube was centrifuged at 1300 RPM for 8 min, and the supernatant was decanted. The pellet was resuspended in 1 ml fixative solution (3 methanol: 1 acetic acid). An additional 4 ml of fixative was added, and the cells were refrigerated for 1 hr. After that, the cells were centrifuged at 1300 RPM for 8 min. The supernatant was decanted and the cells were resuspended in 5 ml of fixative. The previous step was repeated 3 times reducing the volume of fixative by 1 ml each time. After the final centrifugation, the supernatant was decanted and the cells were resuspended in about 1.5 ml of fixative, depending on the size of the pellet. The cells were then dropped using a 5.75 inch paster pipette on a preheated super frosted microscope slide held at a 45 0 angle from a distance of about 10 inches (the slides were preheated in a 65 0 C water bath). The slides were air dried and incubated at 60 0 C for overnight.
For conventional karyotype, cells were banded by dipping slides in trypsin in a coplin jar for 25-30 S. The slides were washed briefly in two saline rinsing solutions. Then, they
were stained with 5% Giemsa in a coplin jar for 6.5 min. The slides were rinsed with tap water and air dried. Finally, the slides were examined under the microscope for metaphases. A minimum of 10 metaphases were randomly chosen and used to determine the karyotype of the tissue culture.
2-MCF10A Cell Cultures and Harvest:
MCF10A cells were grown in 25 cm 2 flasks in 5ml MGEM media (Clonetics).
The media consisted of 500ml of the Bullet Kit bottle, 0.5ml of 10µg/ml hEGF (human recombinant Epithelial Growth Factor), 0.5ml of 5mg/ml Insulin, 0.5ml of 0.5mg/ml Hydrocortisone, 0.5ml of 50mg/ml Gentamycin-50µg/ml Amphotericin, and 2ml of 
3-Spectral Karyotyping (SKY):
The protocol of the manufacturer (Applied Spectral Imaging) was followed with little modifications. On day one, the probe was denatured. Ten µl of the probe mixture (vial #1) was centrifuged briefly, incubated in water bath at 80 0 C for 7 min, and placed in a water bath at 37 0 C for 1 h. In the mean time, the slides were treated with pepsin solution preheated at 37 0 C for 2 min. Then they were washed twice in 1X PBS for 5 min each at room temperature and with 1X PBS/MgCl2 for 5 min. The slides were then incubated in 1% formaldehyde for 10 min at room temperature and washed again with 1X
PBS for 5 min. The slides were dehydrated in 70%, 80% and 90% ethanol for 2 min each.
The chromosomes were denatured by dipping slides in 40 ml of preheated denature solution for 60-90 s at 70 0 C. The slides were again dehydrated in 70%, 80% and 90% ethanol for 2 min each and were allowed to air dry. By that time, the probe from vial#1 was already denatured. The 10 µl probe was transferred to the slide. An 18x18 mm 2 cover slip was placed on the hybridization area leaving no air bubbles. It was sealed with rubber cement. Finally, the slide was transferred to a humidified chamber and placed in an incubator at 37 0 C for 36 hrs.
On day three, the rubber cement and the cover slip were gently taken off. The slides were washed 3 times with washing solution I at 45 0 C for 5 min each. They were then washed twice in washing solution II at 45 0 C for 5 min and once in washing solution III for 2 min at 45 0 C. They were then briefly tilted to drain the fluid and 80 µl of vial#3 was applied. The slides were covered with cover slips (24x60 mm 2 ) and incubated at 37 0 C for 45 min. They were washed again 3 times with washing solution III at 45 0 C for 3 min each. The hybridization area was treated with 80 µl of vial#4, covered with a plastic cover slip and incubated at 37 0 C for 45 min. Again, washing steps with washing solution III were repeated. After that, the slides were washed with water and then air dried. The slides were then stained with 20 µl of DAPI/antifade and covered with cover slips avoiding any air bubbles. The slides were then examined under a fluorescent microscope.
Images were taken and analyzed with the Skyvision Spectral Imaging System. Both the sky color and the DAPI were used to assign chromosomes and to determine the origin of translocated chromosomes.
Reagents for SKY (Applied Spectral Imaging):
-0.01M HCl: 0.5 ml 1M HCl added to 49.5 ml of distilled water.
-1x PBS/MgCl 2 : add 50 ml of 1M MgCl 2 to 950 ml of 1X PBS.
-1% formaldehyde: add 2.7 ml of 37% formaldehyde to 100 ml of 1X PBS/ MgCl 2 .
-Denaturation solution: add 35 ml formamide to 10 ml distilled water and 5 ml 20X SSC.
-Washing solution I: 15 ml 20X SSC, 60 ml of distilled water and 75 ml formamide. Adjust pH to 7.0 with HCl.
-Washing solution II: mix 12.5 ml 20x SSC with 237.5 ml of distilled water.
-Washing solution III: 400 ml of distilled water, 100 ml of 20X SSC and 0.5 ml of Tween 20.
-Vial#1: Probe mixture -Vial#3: buffer one. Prior to use, 10 µl of the buffer were diluted in 1 ml of 4X SSC.
-Vial#4: Buffer two. Prior to use, 5 µl of the buffer were added to 1 ml of 4X SSC.
4-Aneusomy Multi-Probe FISH:
The manufacturer's protocol was used with few modifications (Vysis). Slides were treated in 2X SSC for 2 min at 70 0 C. Then, slides were digested for 10 min at 37 0 C in a protease solution prepared from 0.02g of pepsin, 40ml of H 2 O and 0.4ml of 1N HCl.
Slides were rinsed in PBS at room temperature for 5 min and placed in post fixative solution for another 5 min at room temperature. The post fixative solution consisted of 1ml of 37% formaldehyde, 0.18g of MgCl 2 , and 39ml of PBS (stored at 4 0 C for a maximum of 1 month). Slides were rinsed in PBS for 5 min at room temperature. Finally, slides were dehydrated in ethanol series (70%, 80%, and 90%) for 2 min each. Slides were air dried and were ready for hybridization.
For hybridization, the probe mixture was warmed at room temperature (all work with the probe was performed in the dark). The tube was vortexed and microcentrifuged. were scored for each case with gold for cosmid1p12 probe, red for 8 centromeric probe, green for 11 centromeric probe and aqua for 17 centromeric probe.
5-C-MYC-IGH FISH Probe (Vysis):
The same pretreatment as the above was applied. For hybridization, 10µl of probe mixture (1µl of probe and 49µl of DenHyb) was applied to the slide. Slides were sealed with cover slips and rubber cement and hybridized. Using the HYBrite, program was set at 90 0 C for 4 min and at 37 0 C for 16 hours. After that, the coverslip and the rubber cement were removed. Slides were washed, air dried, DAPI-counterstained and scored (the same as aneusomy probe procedure). The probe for c-myc on chromosome 8q24 appeared in red, the probe for IGH on chromosome 14q32 appeared in green and the probe for chromosome 8 appeared in aqua.
III. Results
Established cell lines from The University of Pittsburgh and one cell line (courtesy of Dr. J. Strobl) were karyotyped. For two of the cultures, DCIS NTAL3 and MCF10A, SKY and FISH probes for both Breast Aneusomy (courtesy of Vysis) and IGH/c-myc (Vysis) were used for their characterization. Based on conventional karyotyping, the composite karyotype was: 45-48,XX,i(1)(q10),-3,del(3)(p13),+4,der(8),+der(9), der(9),+19. Abnormality i(1)(q10) der (8) +der (9) del (3)(p13) 
2-BRL16 (Ductal epithelial hyperplasia and fibrocystic changes).
Figure 6. BRL16 Karyotype.
The composite karyotype of BRL16 was: 44-49,+del(6)(q21)*.
*The del(6)(q21) appeared in 4 out of 11 cells.
3-DCIS NTAL3
Composite Karyotype: 59-110,XX,X,+1,+1,add(1)(p22),+2,+2,+3,+del(3)(p21),+del (3) (q21),+4,+5,+5,+dup(5)(q13q22),+6,+del(6)(q13),+del(6)(q13),+del(6)(q21),+7,+7,+7,+8
,+9,+del(9)(p22),+del(9)(p22),+10,+10,+11,+11,+11,+12,+13,+13,+13,-14,+15, add(15)(p11.2),+16,+16,+17,+17,+17,+del(17)(p13),+del(17)(p13),+18,+18,+19,+19,+19
,+19,+20,+20,+21,+21,+22,+22, +2-19mar[cp10] . 1 Only one additional chromosome was counted per cell. Some cells had more than one addition for a particular chromosome. These were counted as one incidence. 2 Percentages were calculated per 22 conventional karyotypes. 
Chromosomal Aberration
Percentage +del(9)(p22) 68% +del(3)(p21) 64% +del(17)(p13) 59% +del(3)(q21) 45% +del(6)(q21) 27% +del(6)(q23) 22% SKY: IGH/c-myc FISH Probe: 
Chromosomal aberration Percentage
der(2)t(2;15)(q10;q10) 100% der(6)t(6;14)(q13;q11.2) 100% der(1)t(1;19;10)(p13;?;q22) 75% der(15)t(15;22)(p11.2;q11.2) 75% der(4)t(4;20)(q31.1;q11.2) 75% der(2)t(4;2;4)(q21;p11.2q31;p14) 50% der(14)t(14;21)(p11.2;q22) 50% der(2)t(1;2)(p32;p13) 50% der(8)t(2;8)(q33;p11.2) 50% der(1)t(1;6)(q21;q21) 25% der(1)t(1;14)(p22;q11.2) 25% Table IX . IGH/c-myc FISH Probe for DCIS Cells.
Percentages of Cells___________ Extra Signals
Green ( None of DCIS cells had a normal set of aneusomy probes signal. The composite karyotype of BTL12 was: 70-72,XX,+X,+del(1)(q41),+der(1)t(1;2)(p32,q11.2), i(2)(p10),-3,+del(3)(q21),+4,+4,+5,+6,+add(6)(q25),+add(7)(q36),+8,+8,+9,+10,+add(11)(p15), t(11;15)(p11.2;q11.2),del(12)(p11.2),add(13)(q34),+14,+15,+16,+16,+17,+19,+add(19)(q13.3),+20,+20, +21, der (22) Abnormal Chromosomes Percentages* add(11)(p15) 75% der(1)t(1;2)(p32;q11.2) 67% der(11)t(11;15)(p11.2,q11.2) 58% del(3)(p21) 58% del(17)(p13) 58% +add(6)(q25) 42% add(7)(q36) 42% add(13)(q34) 42% der(22)t(2;22) 33% i(2)(p10) 25% *Percentages were based on analysis of 12 cells
Ratio
IV. Discussion
Cytogenetics is an indispensable tool for the study of cancer. It is an important step for research purposes for the identification of frequent chromosomal aberrations.
Once identified, the aberrations can be used for research purposes as a step in the identification of gene(s) involved (i.e. oncogenes or tumor suppressor genes) in carcinogenesis. In addition such findings might be essential for diagnostic and prognostic purposes. Of special interest for this study was breast cancer. Previous research using cytogenetic techniques has shown the involvement of certain abnormalities in breast cancer. In this study, different tissues were analyzed to try to establish the role of NER loss and genetic instability at different levels and to compare the chromosomal aberrations in these levels.
1-MCF10A:
Caruso et al. have shown a der(8) and der(3) in these immortalized non tumor cells. In this study, der(8) was found using SKY (figure 3) and conventional karyotyping (figure 2). The chromosome did not seem to have other chromosomal materials than 8 in
SKY. An amplification of c-myc was suspected. Indeed, FISH ( figure 4) showed an extra c-myc signal in 82% of interphase cells compared to 80% incidence of the der(8) in metaphases karyotypes. Consistent with the previous results from karyotyping and SKY, the cells also had a normal signal for both chromosomes 14q32 and 8 centromere.
Whether c-myc duplication contributes to the immortal characteristic of MCF10A cannot be based on this study. However, it is important to note that the protein is highly expressed in MCF10A cells (Melkoumian et al., 2002) . In fact, MCF10A cells showed higher expression of myc protein than the tumorigenic cell line MCF-7. In addition, based on SKY results, a suspected chromosome 8 was shown to be a del(3)(p13). It also
showed that a previously classified extra chromosome 2 was in fact a der(9). However, an i(1)(q10) was found in 100% of cells. Such chromosome does not only entail the existence of an additional 1q arm but also that one 1p is missing. The loss of 1p was shown to be progressive and recurrent in breast cancer (Larson et al., 2002) . Whether this aberration is an initial event or acquired later, remains to be determined. However, the fact that it was found in a 100% of cells implies that it is an early event. Otherwise, it will appear in some cells but not all. Besides, the cell line seemed to be stable and non cancerous (both passage 14 and 15 had similar karyotypes). Finally, MCF10A had a generally normal signal for the aneusomy FISH probe (figure 5 & Table V) 
2-BRL16:
BRL16 had an abnormal karyotype (figure 6) but relatively stable by their small range of their chromosomal count and the few abnormal events. Chromosomal abnormalities varied between cells. The only consistent event was an extra del(6)(q21) in 4/11 cells (36%). However, in this case, there is an extra 6p rather than a lost 6q.
Nevertheless, 6q is selected against in that cell culture otherwise an additional whole chromosome 6 will be a more likely event. This karyotype could be considered as a link between hyperplasia and 6p.
3-DCIS NTAL3:
Conventional karyotyping of DCIS cells revealed a very aberrant karyotype Nevertheless, a careful look at these karyotypes suggests that additional chromosomes that occurred with lower percentages also had fewer copies and were more likely to be lost in other cells. For instance, chromosome X, which was found in additional number in 27% of cells, had an average copy number of 2.14 per cell; meanwhile one copy was lost in 23% of cells. On the other hand, chromosome 4, which was found in additional number in 95% of cells, had an average copy number of 3.36 per cell, meanwhile one copy was lost only in one cell (less than 5%). Besides, all cells had above normal chromosomal counts (59-110 chromosomes). All these factors suggest that numbers in are equally important.
The selective pressure of carcinogenesis is manifested more clearly in chromosomal aberrations (table VII) because these events are normally less common and more complicated. Thus their recurrence is more relevant to the survival of these cells than to mere chance. The recurrent aberrations included deletions 9p, 17p, 3p, and 6q.
These findings are consistent with previous research (Larson et al., 2002 figure 9 ) has revealed multiple translocations. Some of these aberrations occurred more than once within the same cell, such as der(6)t(6;14)(q13;q11.2). The impact of these translocations cannot be elucidated in this study. However, they are reminiscent of those in leukemias that allow the constitutional expression of an oncogene or a dominant negative protein. Molecular analysis of these translocations might be of great help in identifying these genes. All in all, SKY revealed a great deal of genomic instability manifested by multiple translocations, derivative chromosomes with multiple chromosomal partners and the abundance of small fragments of different chromosomes.
The c-myc FISH probe revealed multiple copies of chromosomes 8, 14 and of cmyc gene (Table IX) . The number of extra chromosomal copies especially for chromosome 14 exceeds that of karyotyping (99% compared to 41%) and that could be due to its participating in different translocations in addition to the small fragments of chromosomal material (which also affected the aneusomy probe). Moreover, a comparison of the number of chromosome 8 copies and c-myc reveals an excess of c-myc in 77% of the cells (Table X) . This is an indication of c-myc amplification in these cells.
In the aneusomy probe (Table XI) , at least one extra red was found in about 90% of cells (similar to the centromere 8 of IGH/c-myc probe). However, this is higher than the proportion of cells with an extra chromosome 8 derived from karyotypes (68%) for the aforementioned reasons. Likewise for chromosome 11 and the green signal in which additional copies were seen in 100% of the cells. The aqua probe for chromosome 17 was the only one to show a loss of one signal in 8% of the cells in contradiction to the karyotypes that reveal additional copies of chromosome 17. This might be due to errors in reading the FISH results since aqua had a small signal. Nevertheless, more than 80% of cells showed extra signal(s) for aqua. Chromosome 1 had a very high proportion of extra signals (a total of 98%) that exceeds the proportion derived from karyotypes (86%).
That is because chromosome 1 was a partner in many translocations and could have been classified in the position of other chromosomes based on the centromere while the probe detects the p arm regardless the origin of the centromere.
4-BTL12:
BTL12 had an abnormal karyotype (figure 11). Cells seemed less heterogenous and more stable than DCIS. That might reflect a monoclonal origin of cells or the high selective pressure that allow cells with very strict prerequisites to reach that phase of cancer (Stage 3A). Only 9 chromosomes were present in extra copies and in different proportions (Table XII) . Noticeably was the loss of chromosome 3 in 17% of the cells.
The cells also showed multiple translocations (Table XIII) . These aberrations will be discussed more thoroughly in the next section.
5-General comparison:
First of all, one of the earliest steps in carcinogenesis is continuous proliferation of cells. In that sense, both MCF10A and BRL16 could be used as models for early events in the evolution of cancer. Of special interest in MCF10A alterations was the 3p deletion, c-myc duplication and i(1)(q10). 3p deletion is consistent in DCIS (64%) and However, once the cells were able to acquire these initial mutations, then they are subjected to a great deal of selective pressure that will only allow certain cells with the appropriate genetic makeup to survive. Indeed, BTL12 (although a more advanced cancer stage) showed fewer chromosomal abnormalities, a narrower chromosomal count range and fewer random events than DCIS. This might suggest that as cells progress through malignancy, the chances for randomness of events decreases because of the higher burden of selective pressure. As a result, one might expect genomic instability to be high in early stages of cancer but that might not hold true for later stages.
Finally, yet another aberration, del(17)p(13), occurred in 59% and 58% of cells in DCIS and BTL12, respectively. The fact that it occurred in DCIS indicates that it is an early event. Since p53 is on that arm, that loss might have a role in the genomic instability in DCIS cells because p53 is very important for cell cycle regulation, apoptosis and DNA repair.
V. Conclusion
This study has shown some events in the carcinogenesis of breast cancer such as; 17p deletion, chromosome 1 aberrations, c-myc duplication, 3p deletion and 6q deletion.
These events were also found in non malignant immortal cells (MCF10A) or in ductal epithelial hyperplasia (BRL16) illustrating for their role as early events. In addition, DCIS cells were shown to manifest a great deal of chromosomal aberrations and genomic instability. That was explained in part by one major event, 3p deletion, because 3p contained three NER genes. The genomic instability could also be explained by 17p deletion because it has the p53 gene. Moreover, genomic instability, in itself, seems to be the mechanism through which cells can achieve malignant transformation. Finally, further research is needed to demonstrate loss of NER in early tumors. Besides, expression studies on suspected regions are needed to show whether genes expression in these regions is altered in malignant transformation. One such region is 1p since it contains numerous oncogenes and participated in many translocations.
